Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0105
+0.0018 (20.00%)
Jul 15, 2025, 4:00 PM EDT

Curative Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
111213112910
Upgrade
Market Cap Growth
32.49%-12.66%17.84%-61.12%201.64%1242.22%
Upgrade
Enterprise Value
141432304610
Upgrade
Last Close Price
0.010.010.020.020.050.03
Upgrade
PB Ratio
-2.13-2.39-4.29-4.5017.486.06
Upgrade
Debt / Equity Ratio
-0.62-0.61-0.72-0.44-0.35
Upgrade
Quick Ratio
0.030.000.030.010.950.24
Upgrade
Current Ratio
0.050.030.110.011.033.21
Upgrade
Return on Equity (ROE)
-----324.55%-612.86%
Upgrade
Return on Assets (ROA)
--64.02%-51.78%-124.69%-133.30%-248.70%
Upgrade
Return on Capital (ROIC)
----2078.82%-162.22%-260.54%
Upgrade
Earnings Yield
-33.44%-30.30%-29.37%-47.06%-18.16%-47.91%
Upgrade
FCF Yield
--8.69%-3.61%-13.11%-5.48%-1.95%
Upgrade
Buyback Yield / Dilution
--37.11%-15.76%-14.18%-53.36%41.32%
Upgrade
Updated Nov 30, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.